Propafenone Shortage Update: What Patients Need to Know in 2026

If you or someone you care for takes propafenone (Rythmol) for a heart rhythm disorder, you may have heard concerns about drug shortages or had difficulty filling a prescription. This article gives you the clearest, most up-to-date picture of propafenone availability in 2026 — including what's causing stocking issues, what the FDA is tracking, and what you can do right now.

Is Propafenone in a National Shortage in 2026?

As of 2026, propafenone is not listed on the FDA's Drug Shortages database as having a declared national shortage. This is generally good news — it means the national supply chain has sufficient manufacturing capacity to meet expected demand. Several generic manufacturers produce propafenone tablets and extended-release capsules, providing redundancy in the supply chain that single-source brand drugs don't have.

However, the absence of a national shortage doesn't mean every pharmacy near you will have propafenone in stock at all times. Local stocking gaps and specific formulation shortages can occur even when national supply is adequate.

Why Are Some Patients Still Having Trouble Finding Propafenone?

Even without a formal FDA-declared shortage, several factors can create real difficulty finding propafenone at your local pharmacy:

Generic Manufacturer Variability

Multiple generic manufacturers — including ANI Pharmaceuticals, Strides, and Aurobindo — produce propafenone. Pharmacies may switch between manufacturer sources based on price and distributor contracts. If a particular manufacturer experiences production delays, the pharmacy's supplier may not immediately have an alternative, causing temporary local gaps.

Extended-Release Formulation (Rythmol SR Generic) Stocking

Patients prescribed propafenone ER capsules (225 mg, 325 mg, or 425 mg) are more likely to encounter stocking issues than those on the immediate-release tablets. The extended-release formulation is prescribed less frequently, so pharmacies order smaller quantities and are more likely to run out when demand spikes.

Broader U.S. Drug Supply Chain Challenges

The United States has experienced historically high numbers of drug shortages in recent years. In 2024, the U.S. had over 300 drug shortages — an all-time high. While propafenone is not among the most severely affected drugs, the overall strain on the pharmaceutical supply chain can affect distribution patterns for many medications, including cardiac drugs.

What Has the FDA Done About Propafenone Availability?

The FDA's drug shortage program monitors medication availability and works with manufacturers to address supply disruptions. For propafenone specifically, the existence of multiple generic manufacturers provides a built-in buffer against single-point-of-failure shortages. The FDA requires manufacturers to notify them of expected supply disruptions, which allows for proactive response.

What Patients Should Do Right Now

Whether propafenone is broadly available or facing localized shortages, these steps protect your medication supply:

1. Don't wait until you're out of medication. Start refilling your prescription at least 7-10 days before you run out. Propafenone for heart rhythm control should never be interrupted suddenly.
2. Consider switching to mail-order pharmacy. Mail-order pharmacies through your insurance plan provide 90-day supplies and have centralized distribution centers less likely to experience localized stocking gaps.
3. Keep your cardiologist informed. If you're having persistent trouble finding propafenone, let your prescribing doctor know. They can help identify solutions or discuss whether your treatment plan needs adjustment.
4. Use medfinder for real-time pharmacy search. medfinder calls pharmacies near you on your behalf to find which ones can fill your propafenone prescription. Results are texted to you directly.

Should You Be Worried About Long-Term Propafenone Availability?

Based on current information, there is no reason to panic about propafenone's long-term availability. The drug is off-patent and has multiple generic manufacturers. It's included in many health insurance formularies as a Tier 1 or Tier 2 drug. However, U.S. drug supply chains can be unpredictable, and staying prepared — with advance refills and a good relationship with your pharmacy and cardiologist — is always the best strategy.

The Bottom Line

In 2026, propafenone is not in a declared national shortage, but localized availability gaps continue to affect some patients. The best approach is proactive: refill early, use mail-order where possible, and use tools like medfinder to locate in-stock pharmacies near you. If you are ever unable to fill your prescription, contact your cardiologist immediately — and read our guide on alternatives to propafenone for more options to discuss with your doctor.